The number of platelet glycoprotein Ia molecules is associated with the genetically linked 807 C/T and HPA-5 polymorphisms

被引:39
作者
Corral, J
Rivera, J
González-Conejero, R
Vicente, V
机构
[1] Hosp Gen Univ, Sch Med, Ctr Reg Hemodonac, Oncohematol Unit, Murcia 300003, Spain
[2] Hosp Gen Univ, Sch Med, Ctr Reg Hemodonac, Unit Hemotherapy, Murcia 300003, Spain
关键词
D O I
10.1046/j.1537-2995.1999.39499235668.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The neutral 807 C/T (Phe(224)) polymorphism (807 C/T polymorphism) of the glycoprotein (GP)Ia gene has been recently associated with the number of GPIa molecules on the platelet surface. The association of the number of GPIa molecules with other GPIa polymorphisms, such as HPA-5 (Glu/Lys(505)) (HPA-5 polymorphism), involved in alloimmune thrombocytopenias is unknown. STUDY DESIGN AND METHODS: The association of the HPA-5 polymorphism with the number of GPIa molecules on the platelet surface in 159 white blood donors was investigated. The genetic linkage between the HPA-5 and the 807 C/T polymorphisms in 316 individuals was also determined. RESULTS: Both the 807 C/T and HPA-5 polymorphisms correlate with the number of GPIa molecules on the platelet surface. The 807 T and HPA-5b alleles are associated with increased numbers of GPIa molecules on the platelet surface. Moreover, the HPA-Sb allele is genetically linked to 15.8 percent of the 807 C alleles. Therefore, the number of GPIa molecules on the platelet surface is dependent on both GPIa polymorphisms as follows: 807 T/T, HPA-5 a/a > 807 C/T, HPA-5 a/b > 807 C/T, HPA-5 a/a > 807 C/C, HPA-5 a/b > 807 C/C, HPA-5 a/a. CONCLUSION: Two GPIa polymorphisms (807 C/T and HPA-5) responsible for the variability in the numbers of GPIa/IIa molecules on the platelet surface in whites have been identified. Despite the genetic linkage between the two polymorphisms, their influence on the number of GPIa molecules on the platelet surface may occur through different mechanisms.
引用
收藏
页码:372 / 378
页数:7
相关论文
共 41 条
  • [1] CHRISTIE DJ, 1991, BLOOD, V77, P2785
  • [2] Corral J, 1996, THROMB HAEMOSTASIS, V76, P735
  • [3] de Moerloose P, 1998, BRIT J HAEMATOL, V100, P735
  • [4] DECKMYN H, 1994, BLOOD, V84, P1968
  • [5] DECKMYN H, 1990, THROMB HAEMOSTASIS, V64, P74
  • [6] Frequency of immune thrombocytopenia in newborns: A prospective study
    Dreyfus, M
    Kaplan, C
    Verdy, E
    Schlegel, N
    DurandZaleski, I
    Tchernia, G
    Aujard, Y
    Baumann, C
    Blot, P
    Boissinot, C
    HurtaudRoux, MF
    Oury, JF
    BlumBoisgard, C
    Daffos, F
    Forestier, F
    Fernandez, H
    Pons, JC
    Vial, M
    Uzan, S
    [J]. BLOOD, 1997, 89 (12) : 4402 - 4406
  • [7] FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
  • [8] Hou M, 1996, EUR J HAEMATOL, V57, P208
  • [9] DEFICIENT COLLAGEN-INDUCED ACTIVATION IN THE NEWBORN PLATELET
    ISRAELS, SJ
    DANIELS, M
    MCMILLAN, EM
    [J]. PEDIATRIC RESEARCH, 1990, 27 (04) : 337 - 343
  • [10] KALB R, 1994, THROMB HAEMOSTASIS, V71, P651